SomnoMed Ltd
RJV
Company Profile
Business description
SomnoMed Ltd is a public company providing treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. Its products include SomnoDent, SomMorning Repositioner, SomnoBrux and SomTab. It produces and sells devices for the oral treatment of sleep-related disorders mainly in Asia Pacific, North America and Europe, with maximum revenue generated from Europe.
Contact
20 Clarke Street
Level 3
Crows Nest
SydneyNSW2065
AUST: +61 294670400
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
Employees
22
Stocks News & Analysis
stocks
CBA earnings: Business lending powers on, but costs and credit bear watching
Our view after the bank reports first quarter earnings.
stocks
Apple earnings review: Revenue beats estimates as memory crunch threatens margins
Apple shares are trading at record highs after posting solid results.
stocks
Nvidia: Cutting our fair value estimate by 19% given the firm’s CEO transition and turmoil
We’re reducing our long-term revenue estimates.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,212.70 | 61.50 | -0.66% |
| CAC 40 | 8,361.36 | 28.49 | 0.34% |
| DAX 40 | 26,771.88 | 109.11 | 0.41% |
| Dow JONES (US) | 52,297.09 | 189.40 | -0.36% |
| FTSE 100 | 10,863.09 | 27.62 | 0.25% |
| HKSE | 23,801.71 | 206.84 | -0.86% |
| NASDAQ | 25,366.09 | 100.10 | -0.39% |
| Nikkei 225 | 61,816.72 | 997.36 | 1.64% |
| NZX 50 Index | 14,181.31 | 77.92 | -0.55% |
| S&P 500 | 7,592.40 | 26.98 | -0.35% |
| S&P/ASX 200 | 9,089.00 | 57.80 | -0.63% |
| SSE Composite Index | 3,660.09 | 4.26 | 0.12% |